copper peptide ghk cu hair growth clinical trial randomized (2016) — Research Summary Copper Peptide 10% GHK-CU, 5%

The effects of antioxidants and inhibitors of apoptosis on cisplatin-induced hearing loss were assessed in ex vivo models

Simple in structure, complex in implication

Clinical trials in retinitis pigmentosa showed 90% patient improvement with increased visual acuity and expanded visual field borders

The most commonly reported side effects in clinical trials include: Nausea Vomiting Diarrhea Constipation Most of these symptoms were mild to moderate and tended to improve over time as the body adjusted to the medication, especially when doses were increased gradually

Phase 2: maintenance (ongoing) After the loading phase, transition to maintenance dosing